Midecamycin Impurity 13 CAS CATO-C4X-312213

Description

The occurrence of Midecamycin Impurity 13 is closely related to a carboxylic acid group, a hydroxyl group, an ether linkage in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.

Midecamycin Impurity 13 (CAS CATO-C4X-312213) is a certified pharmaceutical impurity reference standard with the molecular formula C17H36O7C17H26O3C3H6OC2H6OC3H8C2H6CH2O and a molecular weight of 839.20 g/mol.

The molecular framework of Midecamycin Impurity 13 (C17H36O7C17H26O3C3H6OC2H6OC3H8C2H6CH2O) is characterized by a carboxylic acid group, a hydroxyl group, an ether linkage. In reversed-phase chromatography, its retention is governed primarily by the polarity and ionization state of its functional groups, which provides a practical basis for HPLC-UV/DAD or LC-MS method development.

Recommended for quantitative analysis by HPLC, GC, LC-MS/MS, or GC-MS as an external calibration standard; it can also be used for spiked-recovery experiments, LOD/LOQ determination, and LC-MS/MS multiple-reaction-monitoring (MRM) calibration.

CATO manufactures Midecamycin Impurity 13 under ISO 17034:2016 accreditation with dual CNAS and ANAB accreditation. Each batch is characterized by orthogonal methods and supplied with a full Certificate of Analysis (COA), ensuring metrological traceability.

Physical & Chemical Properties

Why CATO?

• ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
• 130,000+ catalog items in stock, COA supplied with every batch
• Worldwide shipping with full export documentation (HS code guidance available)
• Technical support: +86 18665070610 / Nicole.chen@cato-chem.com